The EU Commission released its proposal in December 2008 designed to deal with the issue of counterfeit drugs.

One of the proposals raised was a ban on repackaging of drugs in Europe. In its current form, this proposal may effectively prohibit the legal practice of "parallel trading" where exporters repackage drugs for export. This is a break from the earlier EU position which supported free movement of goods, and appears to acknowledge that parallel trading weakens the ability to track goods and facilitates counterfeiting.

Other measures in the proposal include anti-tampering seals on medications, electronic batch tracking, and new controls relating to manufacturing and import/exports. This proposal has been criticized by some for doing little to curb Internet sales, which the Commission considers to be an issue of enforcement of existing legislation.

For more information, please see: www.stockholm-network.org/downloads/media/Pharmafocus.pdf; and http://content.usatoday.com/topics/article/European+Commission/08Ik5YR31d27Y/3